Dario A. Paggiarino

Companies

• EyePoint PharmaceuticalsChief Medical Officer Aug 3, 2016 to Apr 2, 2024¹
• Apollo Endosurgery (United States)Sr VP & Chief Dev Officer Apr 22, 2013 to Feb 18, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• EPEyePoint Pharmaceuticals EYPT67,080 shares³$28.3K at $0.42Mar 30, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 30, 2024Shares withheld for tax 7,096 shares at $20.67 of EyePoint Pharmaceuticals³
• Mar 30, 2024Shares withheld for tax 2,957 shares at $20.67 of EyePoint Pharmaceuticals³
• Mar 30, 2024Shares withheld for tax 15,493 shares at $20.67 of EyePoint Pharmaceuticals³
• Mar 30, 2024Exercised options 14,000 shares of EyePoint Pharmaceuticals³
• Mar 30, 2024Exercised options 30,570 shares of EyePoint Pharmaceuticals³
• Mar 30, 2024Exercised options 5,834 shares of EyePoint Pharmaceuticals³
• Feb 9, 2024Shares withheld for tax 2,565 shares at $28.80 of EyePoint Pharmaceuticals⁴
• Feb 9, 2024Shares withheld for tax 2,518 shares at $28.80 of EyePoint Pharmaceuticals⁴
• Feb 9, 2024Exercised options 5,833 shares of EyePoint Pharmaceuticals⁴
• Feb 9, 2024Exercised options 4,967 shares of EyePoint Pharmaceuticals⁴
• Jan 26, 2024Sold 33,665 shares at $25.77 of EyePoint Pharmaceuticals⁵
• Jan 26, 2024Sold 15,609 shares at $25.41 of EyePoint Pharmaceuticals⁵
• Jan 26, 2024Sold 51 shares at $25.41 of EyePoint Pharmaceuticals⁵
• Jan 26, 2024Exercised options 33,665 shares at $13.13 of EyePoint Pharmaceuticals⁵
• Jan 26, 2024Exercised options 51 shares at $13.13 of EyePoint Pharmaceuticals⁵
• Jan 26, 2024Exercised options 15,609 shares at $12.90 of EyePoint Pharmaceuticals⁵
• Jan 25, 2024Sold 300 shares at $25.00 of EyePoint Pharmaceuticals⁶
• Jan 25, 2024Sold 300 shares at $25.00 of EyePoint Pharmaceuticals⁶
• Jan 25, 2024Exercised options 300 shares at $12.90 of EyePoint Pharmaceuticals⁶
• Jan 25, 2024Exercised options 300 shares at $13.13 of EyePoint Pharmaceuticals⁶
• Jan 24, 2024Sold 5,651 shares at $25.02 of EyePoint Pharmaceuticals⁷
• Jan 24, 2024Sold 5,600 shares at $25.01 of EyePoint Pharmaceuticals⁷
• Jan 24, 2024Exercised options 5,600 shares at $13.13 of EyePoint Pharmaceuticals⁷
• Jan 24, 2024Exercised options 5,651 shares at $12.90 of EyePoint Pharmaceuticals⁷
• Jan 23, 2024Sold 3,096 shares at $25.00 of EyePoint Pharmaceuticals⁷